Retraction notice to “Controlled delivery of ketamine from reduced graphene oxide hydrogel for neuropathic pain: In vitro and in vivo studies” [J. Drug Deliv. Sci. Technol. 60 (2020) 101964]

Rui Wang,Jianhu Gan,Renhu Li,Jinghui Duan,Jianjun Zhou,Miaomiao Lv,Rongqin Qi
DOI: https://doi.org/10.1016/j.jddst.2023.104839
IF: 5
2023-08-01
Journal of Drug Delivery Science and Technology
Abstract:This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Editor-in-Chief. Significant similarities were noticed post-publication between this article and an article that was concurrently submitted to the 'Colloids and Surfaces B: Biointerfaces' (COLSUB) journal by an apparently unrelated research group: Hui Li, Yanlu Jia and Chunling Liu, COLSUB 195 (2020) 111259 https://doi.org/10.1016/j.colsurfb.2020.111259. Moreover, the authors did not respond to the journal request to comment on these similarities and to provide the raw data, and the Editor-in-Chief decided to retract the article. One of the conditions of submission of a paper for publication is that authors declare explicitly that their work is original and genuine. As such this article represents a severe abuse of the scientific publishing system. The scientific community takes a very strong view on this matter and apologies are offered to readers of the journal that this was not detected during the submission process.
pharmacology & pharmacy
What problem does this paper attempt to address?